Part,  Chapter, Paragraph

  1    -,     1            |            the European Commission D. G. Health and Consumers (http://
  2    I,     2. 11        |    Nanotechnology. htt ch~Oberdörster G. et al., (2005): Nanotoxicology:
  3    I,     3.  4        |               3.4. References~ ~Beets G, Dourleijn E, Liefbroer
  4    I,     3.  4        |               591-611.~ ~Esveldt, I., G. Beets, K. Henkens, A. Liefbroer &
  5   II,     5.  2.  4    |        moderate alcohol intake (20-30 g/day in men and 10-20 g/day
  6   II,     5.  2.  4    |             30 g/day in men and 10-20 g/day in women) is associated
  7   II,     5.  2.  6    |               intake to less than 1,5 g (3,8 g) per day, an increased
  8   II,     5.  2.  6    |               to less than 1,5 g (3,8 g) per day, an increased intake
  9   II,     5.  2.  6    |         Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina
 10   II,     5.  2.  6    |           1166.~Lewington S, Whitlock G, Clarke R, Sherliker P,
 11   II,     5.  2.  7    |          Vanuzzo D, Pilotto L, Cesana G, Ferrario M, Chiodini P,
 12   II,     5.  2.  7    |         Vanuzzo D, Chiodini P, Cesana G, Ferrario M, Mattiello A,
 13   II,     5.  3.  9    |             1005.~ ~Coleman MP, Gatta G, Verdecchia A, Estève J,
 14   II,     5.  3.  9    |          Oncol 18(3):581-592.~ ~Gatta G, Capocaccia R, Stiller C,
 15   II,     5.  3.  9    |           Appleby P, Barnes I, Reeves G, Endogenous Hormones and
 16   II,     5.  3.  9    |              J, Grosclaude P, Hédelin G, Matsuda T, Moller H, Moller
 17   II,     5.  3.  9    |     Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani
 18   II,     5.  3.  9    |         Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler
 19   II,     5.  5.Int(11)|              and Depression. In: Sen. G., A. George, and P. Östlin (
 20   II,     5.  5.Int(12)|         Diderichsen, A. Härenstam and G. Lindberg (eds) Gender Inequalities
 21   II,     5.  5.  1    |                Lépine JP, de Girolamo G, Vilagut G, Gasquet I, Torres
 22   II,     5.  5.  1    |                de Girolamo G, Vilagut G, Gasquet I, Torres JV, Kovess
 23   II,     5.  5.  2    |             Townsend J, Surr C, Boyle G and Brooker D (2005): Summary
 24   II,     5.  5.  3    |        Sjöström M, Hillger C, Neumann G, Kirch W (in press, due
 25   II,     5.  5.  3    |             12 Suppl 1:74-77.~Andrews G, Sandersson K, Corry J,
 26   II,     5.  5.  3    |         Schulze B, Bertocchi E, Rossi G, Ghilardi A, Pioli R (2007):
 27   II,     5.  5.  3    |                Bernert S, de Girolamo G, Morosini P, Polidori G,
 28   II,     5.  5.  3    |               G, Morosini P, Polidori G, Kikkawa T, Kawakami N,
 29   II,     5.  5.  3    |                Medina-Mora ME, Borges G, Lara C, de Graaf R, Ormel
 30   II,     5.  5.  3    |           Alonsro J, Haro JM, Vilagut G, Bromet EJ, Gluzman S, Webb
 31   II,     5.  5.  3    |               Austin R, Jones-Edwards G, Roberts AP (2006): Lifetime
 32   II,     5.  5.  3    |        Linszen D, Birchwood M, Juckel G, Morrirson A, Vázquèz-Barquero
 33   II,     5.  5.  3    |              Mossialos E, Thornicroft G (2007): Mental Health Policy
 34   II,     5.  5.  3    |     Mackeprang T, Hansson L, Werdelin G, Karlsson H, Bjarnason O,
 35   II,     5.  5.  3    |            Garety P, Geddes J, Orbach G, Morgan C (2002): Psychological
 36   II,     5.  5.  3    |              5):763-82.~Pitschel-Walz G, Bäuml J (2007): Psychotherapie
 37   II,     5.  5.  3    |              55.~Silverstone T, Smith G, Goodall E (1988): Prevalence
 38   II,     5.  5.  3    |             330.~Wölwer W, Buchkremer G, Häfner H, Klosterkötter
 39   II,     5.  5.  3    |             S9-S14.~Forsgren L, Bucht G, Erksson S, Bergmark L (
 40   II,     5.  5.  3    |      Epilepsia 45:1613-1622.~Gallitto G, Serra S, La Spina P, et
 41   II,     5.  5.  3    |                Hauser WA, Gudmundsson G (1998): Long-term survival
 42   II,     5.  5.  3    |             Ludvigsson P, Gudmundsson G, et al (2005): Incidence
 43   II,     5.  5.  3    |             445-450.~Sheth SG, Krauss G, Krumholz A. Li G (2004):
 44   II,     5.  5.  3    |              Krauss G, Krumholz A. Li G (2004): Mortality in epilepsy:
 45   II,     5.  5.  3    |              Europe~Baumhackl U, Eibl G, Ganzinger U, et al (2002):
 46   II,     5.  5.  3    |              Neurol 253:914-918.~Dean G, Elian M, Galea de Bono
 47   II,     5.  5.  3    |              277.~Ekestern E, Lebhart G (2004). Mortality from multiple
 48   II,     5.  5.  3    |         Grønlie SA, Myrvoll E, Hansen G, et al (2000): Multiple
 49   II,     5.  5.  3    |               In: Battaglia MA, Crimi G (eds): An Update on Multiple
 50   II,     5.  5.  3    |           Donald WI, Compston A, Edan G, et al (2001): Recommended
 51   II,     5.  5.  3    |               576.~Middleton LT, Dean G (1991): Multiple sclerosis
 52   II,     5.  5.  3    |        Pugliatti M, Sotgiu S, Solinas G et al (2001): Multiple sclerosis
 53   II,     5.  5.  3    |         Pugliatti M, Sotgiu S, Rosati G (2002): The worldwide prevalence
 54   II,     5.  5.  3    |              134.~Pugliatti M, Rosati G, Carton H, et al (2006):
 55   II,     5.  5.  3    |              722.~Pugliatti M, Rosati G (in press): Epidemiology
 56   II,     5.  5.  3    |           Psychiatry 59:7176.~Rosati G (2001). The prevalence of
 57   II,     5.  5.  3    |          Pugliatti M, Lauer L, Kobelt G (2007): Estimation of the
 58   II,     5.  5.  3    |               Alessandro R, Gamberini G, Granieri E, Benassi G,
 59   II,     5.  5.  3    |      Gamberini G, Granieri E, Benassi G, Naccarato S, Manzaroli
 60   II,     5.  5.  3    |              FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (
 61   II,     5.  5.  3    |              E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P,
 62   II,     5.  5.  3    |             Suppl 1:68-73.~Logroscino G (2005): The role of early
 63   II,     5.  5.  3    |        Klotsche J, Spottke A, Deuschl G, Forstl H, Henn F, Heuser
 64   II,     5.  5.  3    |      neurology 255(2):255-264.~Rosati G, Granieri E, Pinna L, Devoto
 65   II,     5.  5.  3    |      neurologica 1(4):303-308.~Rosati G, Granieri E, Pinna L, Aiello
 66   II,     5.  5.  3    |            243-254.~Späte HF, Gemende G, Gemende I (1988): Psychosocial
 67   II,     5.  5.  3    |             Siebert U, Oertel WH, Ulm G, Dodel R (2005): Cost of
 68   II,     5.  6.  6    |              R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K,
 69   II,     5.  6.  6    |              Andersson HI, Ejlertsson G, Leden I, Rosenberg C (1993):
 70   II,     5.  6.  6    |           Brage S, Nygard JF, Tellnes G (1998): The gender gap in
 71   II,     5.  6.  6    |               M, Emery P, Ferraccioli G, Hazes JM, Klareskog L,
 72   II,     5.  6.  6    |              63S-7S~Lin CT, Albertson G, Price D, Swaney R, Anderson
 73   II,     5.  6.  6    |            Allgar V, Jones K, Marples G, Chandler C, Dawson P (1999):
 74   II,     5.  6.  6    |            Geneva~ ~Symmons D, Turner G, Webb R, Asten P, Barrett
 75   II,     5.  6.  6    |          Roxby M, Simmons A, Williams G (1998): Estimating the burden
 76   II,     5.  7.  7    |             Diseases; 2005.~Ardissino G, Dacco V, Testa S, Bonaudo
 77   II,     5.  7.  7    |               99):S16-S19.~Pontoriero G, Pozzoni P, Vecchio LD,
 78   II,     5.  7.  7    |               DH, Gullion CM, Nichols G, Keith DS, Brown JB (2004):
 79   II,     5.  8.  7    |            Schwartz D, Toren K, Viegi G (2003): American Thoracic
 80   II,     5.  8.  7    |         Bonnefoy X, Carrozzi L, Viegi G, Charpin D, Annesi-Maesano
 81   II,     5.  8.  7    |         Beccaria M, Marinoni A, Viegi G, de Marco R (2003): Chronic
 82   II,     5.  8.  7    |         Fournier M, Housset B, Huchon G, Huas D, Godard P, Voinet
 83   II,     5.  8.  7    |       Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G,
 84   II,     5.  8.  7    |         Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta
 85   II,     5.  8.  7    |        Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi
 86   II,     5.  8.  7    |              1916-1923.~ ~Gudmundsson G, Gislason T, Lindberg E,
 87   II,     5.  8.  7    |            115122.~ ~MacNee W, Viegi G, Kamel N (2007): New opportunities
 88   II,     5.  8.  7    |             Maier WC, Egger P, Visick G, Thakrar B, Sykes J, Pride
 89   II,     5.  8.  7    |               126: 81-89.~ ~Stratelis G, Jakobsson P, Molstad S,
 90   II,     5.  8.  7    |               100: 1349-1355.~ ~Viegi G, Pedreschi M, Pistelli F,
 91   II,     5.  8.  7    |               117: 339S-345S.~ ~Viegi G, Mattelli G, Angino A, Scognamiglio
 92   II,     5.  8.  7    |        339S-345S.~ ~Viegi G, Mattelli G, Angino A, Scognamiglio
 93   II,     5.  8.  7    |          Bednarek M, Gorecka D, Viegi G, Hurd SS, Fukuchi Y, Lai
 94   II,     5.  9.  7    |              Fahlbusch B, Schlenvoigt G, Bischof W, Wichmann HE (
 95   II,     5.  9.  7    |            Figures, ERJ~ ~Mantovani L G, Bettoncelli G, Cricelli
 96   II,     5.  9.  7    |            Mantovani L G, Bettoncelli G, Cricelli C, Sessa E, Mazzaglia
 97   II,     5.  9.  7    |        Cricelli C, Sessa E, Mazzaglia G, Canonica GW, Passalacqua
 98   II,     5.  9.  7    |              Canonica GW, Passalacqua G (2007): Allergic rhinitis
 99   II,     5.  9.  7    |            2004; 59:632-636~ ~Verlato G, de Marco R (2003): Is the
100   II,     5. 10.  7    |           Herouet-Guicheney C, Ladics G, Bannon G, Cockburn A, Crevel
101   II,     5. 10.  7    | Herouet-Guicheney C, Ladics G, Bannon G, Cockburn A, Crevel R, Fitzpatrick
102   II,     5. 11.  3    |            prevalence=5.8%~Girolomoni G, et al~ ~Danish school children (
103   II,     5. 11.  3    |                    M Gonç , T Corr a, G Pessoa, A Bapt a, M Pece o,
104   II,     5. 11.  7    |              2003.~ ~Ceylan C, Ozturk G, Alper S (2003): Non-melanomatous
105   II,     5. 11.  7    |            456-60.~ ~Plesko I, Severi G, Obsitnikova A, Boyle P.
106   II,     5. 12.  7    |           Cancer 86:157-169.~ ~Corrao G, Ferrari P, Zambon A, Torchio
107   II,     5. 12.  7    |        Epidemiol 26:100-109.~ ~Corrao G, Aricò S (1998): Independent
108   II,     5. 12.  7    |          Esposito D, Mele A, Ortolani G, Adamo B, Rapicetta M, Forte
109   II,     5. 12.  7    |         Vergara M, Martin -~ ~Ioannou G, Doust J, Rockey DC (2003):
110   II,     5. 12.  7    |              K, Vanlemmens C, Mantion G, Messner M, Launois B, Samuel
111   II,     6.  4.  5    |            purposes in feed and food; g) give particular attention
112   II,     7.  7        |              2008].~ ~Bauer R, Nossek G, Steiner M (2007): Freizeitunfallstatistik
113   II,     7.  7        |              Peden M, McGee K, Sharma G.~ ~Racioppi F, Eriksson
114   II,     8.  2.  1    |                J., Allan, L., Martin, G. and Robinson, N. (2006).
115   II,     8.  2.  1    |          Quarter 2004, 48-53~Fujiura, G.T., Park, H. J. and Rutkowski-Kmitta,
116   II,     8.  2.  1    |          Cooper S-A, Davis R, Fujiura G, Heller T, Holland A, Krahn
117   II,     8.  2.  1    |            Heller T, Holland A, Krahn G, Lennox N, Meaney J & Wehmeyer
118   II,     8.  2.  1    |     Lantman-de Valk, F.G. Schellevis, G.J. Dinant (2007). Health
119   II,     8.  2.  1    |       Garrido-Cumbrera, M., van Hove, G., Björkman, M., Ceccotto,
120   II,     8.  2.  1    |                R., Kamper, M., Weber, G., Heiss, C., Haveman, M.,
121   II,     8.  2.  3    |                 Quaranta A, Assennato G, Sallustio V (1996): Epidemiology
122   II,     9.  1.  1    |              begin at 22 weeks or 500 g, but that fetal mortality
123   II,     9.  1.  1    |           birth weight less than 2500 g, most recent data available~ ~
124   II,     9.  1.  1    |           Langer M, Vutuc C, Lindmark G (2003): Maternal health
125   II,     9.  1.  1    |       Macfarlane A, Gissler M, Breart G, Zeitlin J (2006): Preterm
126   II,     9.  1.  1    |   Bouvier-Colle MH, Varnoux N, Breart G (1995): Maternal deaths
127   II,     9.  1.  1    |              1995;58(1):3-7.~ ~Breart G, Barros H, Wagener Y, Prati
128   II,     9.  1.  1    |               B, Caneva MP, Schlaeder G (1997) : La surveillance
129   II,     9.  1.  1    |             Cans C, Johnson A, Surman G, Topp M, Torrioli MG, et
130   II,     9.  1.  1    |           very low birthweight (<1500 g) or born prematurely (<32
131   II,     9.  1.  1    |        Blondel B, Alexander S, Breart G (2007): Variation in rates
132   II,     9.  1.  1    |          Zeitlin J, Wildman K, Breart G, Alexander S, Barros H,
133   II,     9.  1.  2    |        appropriate policy response.~ ~g) Much greater investment
134   II,     9.  1.  2    |            Vol 76, pp 693-705.~Bréart G, Barros H, Wagener Y, Prati
135   II,     9.  1.  2    |               C, McDonnell R, Scarano G, Calzolari E, Neville A,
136   II,     9.  1.  2    |        Calzolari E, Neville A, Cocchi G, Bianca S, Gatt M, de Walle
137   II,     9.  1.  2    | Robert-Gnansia E, Daltveit, A, Aneren G, Ollars B, Edwards G (2005a): "
138   II,     9.  1.  2    |           Aneren G, Ollars B, Edwards G (2005a): "Preventing Neural
139   II,     9.  1.  2    |              Vigan C, Fevotte J, Kiel G, Mandereau L, for the Occupational
140   II,     9.  1.  2    |           Dolk H, de Vigan C, Scarano G, Tucker D, Stoll C et al (
141   II,     9.  2.  7    |           Rigby M, Hillger C, Neumann G, Kirch W (2008): Challenges
142   II,     9.  3.  1    |               accessed 11.07.07~ ~Aus G, Bergdahl S, Lodding P,
143   II,     9.  3.  1    |             262~ ~Braun, M., Wassner, G Klotz, T Reifenrath, B Mathers,
144   II,     9.  3.  1    |           Glei DA, Bruzzone S Caselli G (2005): Effects of war losses
145   II,     9.  3.  1    |           Obesity, London.~ ~Jackson, G; Padley, S (2008) Erectile
146   II,     9.  3.  1    |              8(9): 784-796.~ ~Verlato G, Calabrese R, De Marco R (
147   II,     9.  3.  2    |           Langer M, Vutuc C, Lindmark G (2003): Maternal health
148   II,     9.  3.  2    |       Macfarlane A, Gissler M, Breart G, Zeitlin J (2006): Preterm
149   II,     9.  3.  2    |   Bouvier-Colle MH, Varnoux N, Breart G (1995): Maternal deaths
150   II,     9.  3.  2    |              1995;58(1):3-7.~ ~Breart G, Barros H, Wagener Y, Prati
151   II,     9.  3.  2    |               B, Caneva MP, Schlaeder G (1997) : La surveillance
152   II,     9.  3.  2    |             Cans C, Johnson A, Surman G, Topp M, Torrioli MG, et
153   II,     9.  3.  2    |           very low birthweight (<1500 g) or born prematurely (<32
154   II,     9.  3.  2    |               van Roosmalen J, Dekker G, van Dongen P, van Geijn
155   II,     9.  3.  2    |        Blondel B, Alexander S, Breart G (2007): Variation in rates
156   II,     9.  3.  2    |          Zeitlin J, Wildman K, Breart G, Alexander S, Barros H,
157   II,     9.  3.  3    |             gender-related issues” (e.g.violence).~ ~On 3 July 2002,
158   II,     9.  3.  3    |                    Del Amo J, Broring G, Hamers FF, Infuso A, Fenton
159   II,     9.  3.  3    |             Qual A, Rundle K, Cousins G, Donnelly C, Mulcahy F,
160   II,     9.  3.  3    |        Shepherd J, Weston R, Peersman G, Napuli IZ, Interventions
161   II,     9.  4.  7    |               10.07.07~ ~Cattaneo, A. G. (2007): Tuberculosis surveillance
162   II,     9.  5.  6    |              F, Härenstam A, Lindberg G). Harvard Center for Development
163   II,     9.  5.  6    |                10) 2221-2232~Heinrich G A (2000): Affluence And
164   II,     9.  5.  6    |               Publications~ ~Lindholm G (1995): ÎSkolgrden, -vuxnas
165   II,     9.  5.  6    |              1), pp. 13-28.~ ~Risberg G, Hamber K, Johansson E (
166  III,    10.  1.  3    |            Brasel JA, Lee W-NP, Burke G, Cooper DM (1998): Fitness
167  III,    10.  1.  3    |         Alcohol 13:387-405.~Dahlgren, G. & Whitehead, M. (1991):
168  III,    10.  1.  3    |        Circulation 90:2581-2590.~Gmel G, Rehm J (2003): Harmful
169  III,    10.  2.  1    |               between 0.8g/l and 0.99 g/L.~There is a relationship
170  III,    10.  2.  1    |                a consumption of 15-30 g ethanol /day throughout
171  III,    10.  2.  1    |        Caetano R, Casswell S, Edwards G, Giesbrecht N, Graham K,
172  III,    10.  2.  1    |                  Gherunpong S, Tsakos G, Sheiham A. A s s. Int J
173  III,    10.  2.  1    |       Lingstrom P, Mejare I, Norderam G, Norlund A, Petersson LG,
174  III,    10.  2.  1    |              pdf].~ ~Evans J, Roberts G (1987): Physical competence
175  III,    10.  2.  1    |            Dietary-history~28~Mensink G B M et.al. (2004) Food and
176  III,    10.  2.  1    |               birth weight (over 4500 g or above the 95th percentile
177  III,    10.  2.  1    |           survey: summary statistics. G’Mangia, Department of Health
178  III,    10.  2.  1    |              in Hungarian).~ ~Boström G (2007): Resultat från nationella
179  III,    10.  2.  1    |              October 2007).~ ~Bostrom G, Diderichsen F (1997): Socioeconomic
180  III,    10.  2.  1    |           Zuccaro P, Negri E, Apolone G, La Vecchia C (2006): Overweight
181  III,    10.  2.  1    |            Friel S, Corrigan H, Nolan G, Sixsmith J, Walsh O, Cooke
182  III,    10.  2.  1    |             Bíró L, Greiner F, Zajkás G, Szórád I, Varga A, Domonkos
183  III,    10.  2.  1    |          Peeters PH, Engeset D, Skeie G, Aller A, Amiano P, Berglund
184  III,    10.  2.  1    |           Aller A, Amiano P, Berglund G, Nilsson S, McTaggart A,
185  III,    10.  2.  1    |              V, Evangelista A, Frasca G, Bueno-de-Mesquita HB, van
186  III,    10.  2.  1    |           Schouw YT, Engeset D, Skeie G, Tormo MJ, Ardanaz E, Charrondiere
187  III,    10.  2.  1    |            Ocke MC, Peeters PH, Skeie G, Engeset D, Charrondiere
188  III,    10.  2.  1    |  Bueno-De-Mesquita HB, Ocke MC, Skeie G, Kumle M, Dorronsoro Iraeta
189  III,    10.  2.  1    |              P, Kalapothaki V, Masala G, Giurdanella MC, Norat T,
190  III,    10.  2.  1    |                Vasilopoulou E, Bellos G, Pala V, Masala G, Tumino
191  III,    10.  2.  1    |              Bellos G, Pala V, Masala G, Tumino R, Sacerdote C,
192  III,    10.  2.  1    |          Peeters PH, Engeset D, Skeie G, Slimani N, Riboli E (2006):
193  III,    10.  2.  3    |               intake to less than 1,5 g (3,8 g) per day, an increased
194  III,    10.  2.  3    |               to less than 1,5 g (3,8 g) per day, an increased intake
195  III,    10.  2.  4    |              Washington~ ~Gao J, Shan G, Sun B, Thompson PJ, Gao
196  III,    10.  2.  4    |       Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998):
197  III,    10.  2.  4    |           Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli
198  III,    10.  2.  4    |                Kallioniemi OP, Sauter G (2001): Tissue microarrays
199  III,    10.  2.  5    |               377-82~Madigan S, Moran G, Schuengel C (2007): Unresolved
200  III,    10.  3.  1    |               Oberaigner W, Pershagen G, Ruano-Ravina A, Ruosteenoja
201  III,    10.  3.  2    |     concentrations (TEq) of ca. 10 pg/g in Hungary to ca. 40 pg/
202  III,    10.  3.  2    |               in Hungary to ca. 40 pg/g in the Netherlands. The
203  III,    10.  3.  2    |        concentrations are about 10 pg/g (range of 5-20) in most
204  III,    10.  3.  2    |              of for S-PBDE of 2.49 ng/g fat which is comparable
205  III,    10.  3.  2    |                MA Palacios, MM Gomez, G Morrison, S Rauch, C McLeod,
206  III,    10.  4.  2    |            human health (100 bacteria/g). However, in RTE fishery
207  III,    10.  4.  2    |              samples over the 100 cfu/g limit were made indicating
208  III,    10.  4.  2    |               found in trouts: 0.02µg/g fish based on a TDI (Tolerable
209  III,    10.  4.  2    |             WHO recommendation of 400 g fruit and vegetables/day (
210  III,    10.  4.  2    |             in case of an emergency; (g) that the feed and food
211  III,    10.  5.  1    |          Planning. Sweden.~Richardson G, Eick S, Jones R (2005):
212  III,    10.  5.  1    |                       Simoni M, Viegi G, Canciani M, Sestini P (
213  III,    10.  5.  1    |       Gunnarsson K, Runeson R, Smedje G (2007) Physiological and
214  III,    10.  5.  2    |               256.~ ~Jones A, Bentham G. (1997): Health service
215  III,    10.  5.  2    |          January 23, 2008)~ ~O'Reilly G, O'Reilly D, Rosato M, Connolly
216  III,    10.  6.  1    |              R, Van Kesteren J, Hideg G, Nevala S (2005): The burden
217  III,    10.  6.  2    |         University Press.~ ~Dahlgren, G. & Whitehead, M. (1991).
218  III,    10.  6.  2    |            Breeze E, Cambois E, Costa G, Geurts JJM, Lahelma E,
219   IV,    11.  6.  5    |                18(2), p 364.~ ~Carrin G, Hanvoravongchai P (2003): "
220   IV,    11.  6.  5    |                 McDaid D, Thornicroft G (2005): Mental health II:
221   IV,    11.  6.  5    |         Welfare and Sport.~ ~ ~Mooney G, HallJ et al. (1991): "Utilisation
222   IV,    11.  6.  5    |       Economics 10: 475–480.~ ~Mooney G, Hall J et al. (1992): "
223   IV,    12.  5        |                 Disease registers (e. g. cancer, myocardial infarction,
224   IV,    12.  5        |                 Sentinel Networks (e. g. diseases not under mandatory
225   IV,    12.  5        |              Surveillance Measures(e. g. Notifiable Infectious diseases)~-
226   IV,    12.  5        |               Administrative data (e. g. health insurance data,
227   IV,    12.  5        |             staff)~- Process data (e. g. data on health care supply
228   IV,    12.  5        |                 Data from Surveys (e. g. population representative
229   IV,    12. 10        |            vegetables, preferably 600 g/d for adults and children (>
230   IV,    12. 10        |              10 years of age) and 400 g/d for children (4-10 years
231   IV,    12. 10        |           some cases federal) laws e. g. against smoking at public
232   IV,    12. 10        |          children/adolescents (see e. g. www o) including quit-lines (
233   IV,    12. 10        |    non-governmental organisations (e. g. German Medical Association/
234   IV,    12. 10        |               since 2004): targets e. g. prevention of diabetes
235   IV,    12. 10        |              local infrastructure (e. g. cycle paths, public gyms
236   IV,    12. 10        |           self-help organizations (e. g. drug counselling centres).~ ~
237   IV,    12. 10        |          different sorts of drugs (e. g. “Quit the shit”-program
238   IV,    12. 10        |               on health behaviour (e. g. information concerning
239   IV,    12. 10        |               radiation there are, e. g., X-ray diagnostics in medicine,
240   IV,    12. 10        |             early warning systems (e. g. on heat waves) that are
241   IV,    12. 10        |         additional information see e. g. German Registry for Somatic
242   IV,    12. 10        |            bioethical subjects see e. g. Federal Ministry of Justice (
243   IV,    12. 10        |       population who eat at least 500 g fruit and/or vegetables